Document:

Exhibit 4

Exhibit 4.14

ASSIGNMENT

WHEREAS ImmPheron, Inc. ( Assignor ), of 5235 Athens-Boonseboro Road, Lexington, Kentucky, 40509, being the owner of certain inventions or improvements described and claimed in the United States Letters Patent No. 6,238,667 and entitled:

Method of Affinity Cross-Linking Biologically Active, Immunogenic Peptides

to Antibodies

AND WHEREAS, InNexus Biotechnology International Limited, having an office at 1400 — 400 Burrard Street, in the City of Vancouver, in the Province of British Columbia (the Assignee), is desirous of acquiring the entire right, title and interest in and to the said inven­tions or improvements, and in, to and under all Letters Patent which may be granted on or as a result thereof in all countries;

NOW THEREFORE, in consideration of ONE ($1.00) DOLLAR and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Assignor, does hereby sell, assign, transfer and set over to the Assignee the entire right, title and interest in and to the said inventions or improvements, and in, to and under all Letters Patent which may be granted on or as a result thereof, and any reissue or reissues of said Letters Patent; and does assign to and authorize the Assignee to file in its name applications for Letters Pat­ent for said inventions or improvements in all countries, the same to be held and enjoyed by the Assignee, its successors, assigns, nominees or legal representatives, to the full end of the term or terms for which said Letters Patent respectively may be granted, reissued or extended, as fully and entirely as the same would have been held and enjoyed by Assignor, had this as­signment, sale and transfer not been made;

AND Assignor hereby covenants that it has full right to convey the entire interest herein as­signed, and that it has not executed and will not execute any agreement in conflict herewith, and further covenants and agrees that it will, each time request is made and without undue delay, execute and deliver all such papers as may be necessary or desirable to perfect the title to said inventions or improvements and said Letters Patent, in the Assignee, its successors, assigns, nominees or legal representatives, and Assignor agrees to communicate to the As­signee, or its nominees, all known facts respecting said inventions or improvements and said Letters Patent, to testify in any legal proceedings, to sign all lawful papers, to execute all dis­claimers and divisional, continuing, reissue and foreign applications, to make all rightful oaths, and generally to do everything possible to aid the Assignee, its successors, assigns, nominees and legal representatives to obtain and enforce for its or their own benefit, proper patent pro­tection for said inventions or improvements in all countries, all at the expense, however, of the Assignee or its successors, assigns, nominees or legal representatives;

- 1 -

AND Assignor hereby authorizes and requests the Commissioner of Patents and Trademarks of the United States of America and any official of any country or countries foreign to the United States of America, to issue to the Assignee, as assignee of the entire right, title and in­terest, all Letters Patent for said inventions or improvements in accordance with the terms of this Assignment.

EXECUTED at Fayette Co. , State of Kentucky this 27th  day of June, 2003.

“Heinz Kohler”

Heinz Kohler

President ImmPheron, Inc.

 

/s/

NOTARIAL CERTIFICATE

On this 27th day of June, 2003, before me, personally appeared Heinz Kohler. known to me to be the individual who executed the foregoing instrument, and who acknowl­edged to me that he executed the same of his own free will and for the purpose therein set forth.

William R. Moses,

Notary Public in and for the State of

Kentucky, U.S.A.

My Commission expires the 27th  day of April, 2006 

STATEMENT OF ACCEPTANCE

The foregoing Assignment is hereby accepted by the  Assignee:

“Stuart Rogers”

(C/S)

By:  Stuart Rogers, President

Title:

Date:CONSULTING AGREEMENT

11

Exhibit 4.15

CONSULTING AGREEMENT

THIS AGREEMENT dated for reference September 20, 2002.

BETWEEN:

NVR CAPITAL CORPORATION, of 304-318 Homer Street, Vancouver, B.C., V6B 2V2 

 (hereinafter called the "Consultant")

OF THE FIRST PART

AND:

CUSIL VENTURE CORPORATION, a corporation incorporated under the laws of British Columbia and having an office at 1400-400 Burrard Street, Vancouver, B.C. V6C 3G2

(hereinafter called the “Company”)

OF THE SECOND PART

WHEREAS:

A.

The Company wishes to acquire and the Consultant wishes to supply the services described herein upon the terms and conditions set out in this Agreement;

NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the mutual premises and covenants contained in this Agreement, the parties hereto covenant and agree as follows:

1.

Provision of Services

1.1

Subject to the terms of this Agreement, the Consultant shall provide to the Company the services listed in Schedule "A" hereto and all such other services as are necessarily incidental thereto that may be required by the Company (the "Services").

1.2

The Consultant shall use its best efforts to further the interests of the Company in providing the Services.

1.3

The Consultant shall engage or employ Norman van Roggen as an employee during the term of this Agreement (the "Key Employee") and shall assign the Key Employee to perform its obligations hereunder.

2.

Changes in Service

2.1

The Company shall be entitled to order changes and/or deletions from the Services as set out in Schedule "A" by giving written notice to the Consultant without invalidating this Agreement.  The Consultant shall be deemed to have agreed to such changes and/or deletions and the Services to be provided hereunder shall be modified accordingly unless the Consultant objects in writing within five days of receipt of such notice.

3.

Remuneration of Consultant

3.1

The Company shall pay the Consultant the sum of $5,000 per month per month payable on the first day of each month during the term of this Agreement in consideration of the Consultant's performance of the Services as required by this Agreement.  Subject to such restrictions and requirements as the Company may impose from time to time, the Company shall reimburse the Consultant for out-of-pocket expenses incurred in performance of the services upon receipt of such evidence of those expenses as the Company may reasonably require.  

3.2

The Consultant or, if so directed by the Consultant, the Key Employee shall be entitled to receive incentive stock options entitling the holder to purchase 200,000 common shares of the Company at a price of $0.50 per share for a term of twenty-four months, vesting quarterly over the first 12 months, subject to such further or other terms and conditions as may be acceptable to the TSX Venture Exchange and the Company and such other conditions as may be specified in Schedule “A” hereto.  

3.3

The Consultant represents and warrants that all of its outstanding voting shares are beneficially owned and controlled by the Key Employee.

4.

Consultant Not Agent or Employee

4.1

Neither the Consultant nor its Key Employee shall be the employee or agent of the Company and accordingly, neither shall purport to enter into any a contract or subcontract on behalf of the Company or otherwise purport to act on its behalf.  Nothing in this Agreement shall be deemed to require the Consultant to provide its services exclusively to the Company and the Consultant hereby acknowledges that the Company shall not be required to make any remittances or payments required of employers by statute on the Consultant's or the Key Employee's behalf and the Consultant or any of its agents or employees shall not be entitled to the fringe benefits provided by the Company to its employees.

4.2

The Company acknowledges that since the Consultant is an independent contractor and not an employee of the Company, the Consultant shall, except where expressly provided herein, have direction and control of the manner, methods, techniques and procedures used by its agents or employees to perform the Services.

4.3

The Consultant acknowledges and agrees that, where all or a portion of the compensation includes incentive stock options the Key Employee shall (at the Company’s sole election) be appointed as either an officer of the Company with the title of Manager, Corporate Communications or such other title as the Company’s board of directors may approve, or shall function as a dependant contactor of the Company and, in particular, shall provide the services set out herein on a continuing and regular basis for the minimum time per week set out in Schedule “A” and the Company shall have the same direction and control over the details and methods of work of the Key Employee as if the Key Employee were an employee of the Company for whom income tax deductions were made at source.

5.

Facilities

5.1

The Consultant shall provide all the facilities (including office space, typing, document reproduction, computer programming and other clerical assistance) that may be required by the Consultant to perform the Services.

6.

Books and Records

6.1

The Consultant shall keep proper accounts and records of all expenditures made by it in connection with the Services, and of the time expended by it or any of its agents or servants in performing the Services and all invoices, receipts and vouchers relating thereto.

7.

Company's Obligations

7.1

The Company shall make available to the Consultant such information and data and shall permit the Consultant, its agents and employees to have access to such documents or premises as are reasonably necessary to enable it to perform the Services.

8.

Confidentiality and Ownership of Work Product

8.1

All reports, documents, concepts, reports, financial records, products, technology, and processes together with any marketing schemes, business or financing contacts, or information pertaining to prospective acquisitions, joint ventures or business combinations or any business opportunities prepared, produced, developed, or acquired, by or at the direction of the Consultant, directly or indirectly, in connection with or otherwise developed or first reduced to practice by the Consultant in the course of performing Services pursuant to this Agreement including, without limiting the generality of the foregoing, all inventions, discoveries, designs, concepts and results of reach and development (whether or not reduced to writing and whether or not patentable or protectable by copyright), financial or accounting information, analysis, projections, data (whether in electronic or other form), contact lists, and contract sheets, financing leads, sales material and marketing, financial or technical information pertaining to the Company’s business (collectively, the “Work Product”) shall belong exclusively to and shall be the sole property of the Company and the Company shall be entitled to all right, title and interest therein, and all profits, or benefits therefrom.  No copies, summaries or other reproductions of any Work Product shall be made by the Consultant without the express permission of the Company and the Consultant shall, forthwith upon the Company’s request, deliver to the Company all Work Product in the possession of or otherwise available to or under the control of the Consultant notwithstanding a termination of this Agreement.

8.2

The Consultant shall not at any time either during the term of this Agreement or thereafter divulge to any person, firm or corporation, any information, documents or Work Product (other than information, documents or Work Product which the Company has authorized for public disclosure or which has previously been disclosed to the public) received by him during the course of its providing the Services to the Company with regard to the personal, financial or other affairs of the Company or any of it subsidiaries, or the Company’s directors, officers and employees and all such information shall be kept confidential and shall not in any manner be revealed to anyone by the Consultant, except as may be required by law or otherwise permitted by the Company in writing.

8.3

The Consultant shall comply, and shall take proper measures to cause all employees of the Consultant or other persons under its direction or control to comply, with such directions as the Company shall make to ensure the safeguarding or confidentiality of all such information, documents, and Work Product.

9.

Duties of Consultant

9.1

During the term of this Agreement, the Consultant shall devote such of its time, attention and abilities to the business of the Company as is reasonably necessary for the proper exercise of its duties pursuant to this Agreement.  Nothing contained herein shall be deemed to require the Consultant to devote its exclusive time, attention and ability to the business of the Company.

9.2

During the term of this Agreement, the Consultant shall ensure that its Key Employee will:

(a)

at all times except when disabled by sickness or incapacity, faithfully and diligently perform his duties and use his best efforts to promote and advance the business of the Company;

(b)

devote such of his time, labour and attention to the business of the Company as is necessary for the proper exercise of the Consultant's duties hereunder and, except as otherwise provided herein, refrain from engaging in any business, venture, or other commercial or sales activities that in any way conflict with or detract from his ability to fulfill his duties in the manner contemplated in this paragraph; and

(c)

refrain from acting in any manner contrary to the interests of the Company or contrary to the duties of the Consultant as contemplated herein.

9.3

Without limiting the generality of the foregoing, the Consultant shall not during the term of this Agreement:

(a)

act in any manner contrary to the terms of this Agreement, or the best interests of the Company; or

(b)

take advantage for personal gain, either directly or indirectly, of a business opportunity, which opportunity arose because of the Consultant's relationship with the Company unless such opportunity is first presented to the Company and the Company expressly declines to take advantage of or pursue such opportunity and agrees in writing that the Consultant may take advantage thereof.

\\Allen\allen_d\My Documents\Files\PUBLIC COMPANIES\InNEXUS BIOTECHNOLOGY INC\SEC\OCR DOCS FROM STU\EX 4-15 NVR Agreement.rtf

11

10.

Liability of Consultant

10.1

The Consultant shall indemnify and save the Company harmless from and against all costs, expenses, losses, damages and obligations it may suffer or incur as the result of the breach of any covenant or warranty made by the Consultant in this Agreement.

11.

Termination

11.1

The term of this Agreement shall be for 12 months and shall commence upon September 20, 2002 and unless terminated earlier pursuant to the provisions hereof, or unless renewed in writing by the parties shall expire on the 19th day of September, 2003. 

11.2

This Agreement may be terminated prior to the completion of the Services as follows:

(a)

by either party upon 30 days' prior written notice; or

(b)

immediately upon the Company giving written notice to the Consultant of the occurrence of an Event of Default as defined in clause 11.4.

If either party fails to give any such notice, this Agreement shall continue in full force and effect.

11.3

Upon the termination of this Agreement, the Company shall, subject to its right to set off any damages or other amounts claimed by the Company from the Consultant, pay to the Consultant all amounts accruing hereunder up to and including the effective date of termination.

11.4

An Event of Default shall be deemed to occur if:

(a)

the Consultant is in breach of any covenant, obligation or warranty hereunder and such breach continues for a period of seven (7) days after written notice thereof has been given to the Consultant; or

(b)

the Consultant becomes insolvent or unable to discharge its liabilities generally as they become due, makes an assignment for the benefit of its creditors, or is made subject to a petition or other proceedings in bankruptcy.

\\Allen\allen_d\My Documents\Files\PUBLIC COMPANIES\InNEXUS BIOTECHNOLOGY INC\SEC\OCR DOCS FROM STU\EX 4-15 NVR Agreement.rtf

11

12.

Non-Assign ability

12.1

The Consultant shall not subcontract to any person, any right, duty or obligation hereunder without the prior written consent of the Company.  This Agreement may not be assigned by either party without the prior written consent of the other party.

13.

Co-operation with Other Parties

13.1

The Consultant shall co-operate with all other parties engaged or employed by the Company from time to time and shall coordinate its activities with the activities of such parties as and when requested by the Company.

14.

Force Majeure

14.1

Notwithstanding anything herein to the contrary, neither party hereto shall be deemed to be in default with respect to the performance of the terms, covenants and conditions of this Agreement if the same shall be due to any strike, lock-out, civil commotion, invasion, rebellion, hostilities, sabotage, governmental regulations or controls, or acts of God.

15.

Notice

15.1

All notices, demands and payments required or permitted to be given hereunder shall be in writing and may be delivered personally, or sent by telegram or telex or other means of electronic communication providing a printed copy ("Electronic Communication") or may be forwarded by first class prepaid registered mail to the addresses set forth below.  Any notice delivered or sent by Electronic Communication deemed to have been given and received at the time of delivery.  Any notice mailed as aforesaid shall be deemed to have been given and received on expiration of 72 hours after it is posted, addressed to the Company or the Consultant at their respective addresses or telefax numbers set out above or such other address or addresses or telefax numbers as the parties may from time to time give notice of in writing; provided that if there shall be between the time of mailing and the actual receipt of the notice a mail strike, slow down or other labour dispute which may affect the delivery of such notice by the mails, then such notice shall be effective only if actually delivered.

\\Allen\allen_d\My Documents\Files\PUBLIC COMPANIES\InNEXUS BIOTECHNOLOGY INC\SEC\OCR DOCS FROM STU\EX 4-15 NVR Agreement.rtf

11

16.

Entire Agreement

16.1

The provisions herein contained constitute the entire agreement between the parties and supersede all previous communications, representations and agreements, whether oral or written, between the parties with respect to the subject matter hereof.

17.

Further Assurances

17.1

Each of the parties shall execute such other documents and instruments and shall do such other acts as may be necessary to implement and carry out the intent of this Agreement.

18.

Proper Law

18.1

The proper law of this Agreement is the law of British Columbia.

19.

Time of Essence

19.1

Time is of the essence of this Agreement.

20.

Waiver of Breach

20.1

The waiver by either the Company or the Consultant of a breach of any provisions of this Agreement by the other party to this Agreement shall not operate or be construed as a waiver of any subsequent breach by that party.

21.

Regulatory Approval

21.1

This Agreement is subject to the approval of all regulatory authorities as may have jurisdiction (the "Regulatory Authorities").

\\Allen\allen_d\My Documents\Files\PUBLIC COMPANIES\InNEXUS BIOTECHNOLOGY INC\SEC\OCR DOCS FROM STU\EX 4-15 NVR Agreement.rtf

11

IN WITNESS WHEREOF the parties have affixed their common seal hereto in the presence of their officers duly authorized for that purpose.

The Common Seal of

)

NVR CAPITAL CORPORATION

)

was hereunto affixed in the presence of:

)

)

)

  /s/ Norman Van Roggen                              

)

c/s

Authorized Signatory

)

)

                                                                       

)

Authorized Signatory

)

The Common Seal of 

)

CUSIL VENTURE CORPORATION

)

was hereunto affixed in the presence of:

)

)

)

  /s/ Stuart Rogers                                            

)

c/s

Authorized Signatory

)

)

                                                                

)

Authorized Signatory

)

\\Allen\allen_d\My Documents\Files\PUBLIC COMPANIES\InNEXUS BIOTECHNOLOGY INC\SEC\OCR DOCS FROM STU\EX 4-15 NVR Agreement.rtf

11

SCHEDULE "A" 

TO THE CONSULTING AGREEMENT DATED FOR REFERENCE SEPTEMBER 20, 2002

BETWEEN CUSIL VENTURE CORPORATION AND NVR CAPITAL CORPORATION.

DUTIES AND COMPENSATION

	TERM OF AGREEMENT AND MINIMUM TIME

	12 Months commencing September 20, 2002, part time, as required for completion of duties

	 	 
	SERVICES AND DUTIES:

	 
	Title For Key Employee:

	Manager, Corporate Communications

	 	 
	Duties:

	1.

The Consultant shall, in co-operation with such other persons as the Company may specify:

a)

consult with and advise the Company with respect to investor relations programs and corporate communications;

b)

introduce the Company to brokerage firms, securities dealers, consultants and other persons who may assist the Company in its financing efforts and business affairs where appropriate;

2.

provide the services of the Key Employee in the capacity set out below and cause the Key Employee to Perform all the duties commonly associated with the position of Manager, Corporate Communications including: 

a)

communicating corporate information with institutional or retail investors, existing shareholders, analysts, investment letter writers, business publishers  and stock brokers on a regular basis determined by the Company

b)

Sendind authorized corporate information to existing shareholders or prospective investors in answer to inquiries or contacts;

c)

promptly follow-up investor contracts with phone calls or, where appropriate and warranted, personal visits;

d)

maintaining written up-to-date “call sheets” and other records of communication with specific investors, including information specified by the Company;

e)

maintaining a database, in both electronic and paper format, for shareholders, institutions, brokers and prospective investors who have been contacted by the Consultant with respect to the Company during the term of this Agreement.  The consultant shall deliver to the Company, as from  time to time, a copy of this database in both electronic and paper format, as requested by the Company;

f)

communicate results of efforts regularly with the designated Company representative;

3.   use all proper means in the Consultant’s power to maintain and improve the Company’s corporate communications and investor relations programs including, in particular, its relationships with institutional investors, and to protect and further the interests of the Company.

	COMPENSATION:

	 
	Monthly Compensation:

	$5,000 per month 

	 	 
	Commissions:

	None

	 	 
	Benefits:

	none 

	 	 
	Other Benefits:

	Incentive Stock Options - 200,000 shares at $0.50 per share exerciseable for twenty-four months, vesting in stages over 12 months from the date of issuance with 1⁄4 of such options vesting every 3 months, in accordance with TSX Venture Exchange requirements with respect to options granted to investor relations personnel.

Such bonuses and other compensation as may be granted from time to time for locating financing and other activities beyond normal job duties on terms approved by the Directors and, where required, the TSX Venture Exchange.

	 	 

\\Allen\allen_d\My Documents\Files\PUBLIC COMPANIES\InNEXUS BIOTECHNOLOGY INC\SEC\OCR DOCS FROM STU\EX 4-15 NVR Agreement.rtf

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}]]